Shares of Avacta Group Plc (LON:AVCT – Get Free Report) passed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 57.99 ($0.73) and traded as low as GBX 48 ($0.60). Avacta Group shares last traded at GBX 48.70 ($0.61), with a volume of 516,713 shares.
Avacta Group Price Performance
The company has a debt-to-equity ratio of 63.54, a quick ratio of 4.96 and a current ratio of 1.29. The stock’s 50-day moving average is GBX 49.30 and its two-hundred day moving average is GBX 58.11. The stock has a market cap of £174.49 million, a PE ratio of -541.11 and a beta of 1.12.
Avacta Group Company Profile
Avacta Group Plc develops cancer therapies and diagnostics in the United Kingdom, France, North America, South Korea, and rest of Asia and Europe. The company operates through Diagnostics and Therapeutics segments. It develops products based on its proprietary Affimer and pre|CISION technology platforms.
Featured Articles
- Five stocks we like better than Avacta Group
- 3 Grocery Stocks That Are Proving They Are Still Essential
- Power Up: Gaming Industry Expansion Fuels Stock Opportunities
- The Most Important Warren Buffett Stock for Investors: His Own
- These 3 Quirky ETFs May Be Strong Plays in 2025
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- Buffett Takes the Bait; Berkshire Buys More Oxy in December
Receive News & Ratings for Avacta Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avacta Group and related companies with MarketBeat.com's FREE daily email newsletter.
